Identify Individuals with Diabetes Who Are at Greater Risk of Heart Disease and Stroke by Utilizing MyHap2™
The management of Diabetes patients specific to the morbidity and mortality associated with cardiovascular disease and stroke is a priority for health care providers.
Haptoglobin is consistently associated as a marker in risk factor for cardiovascular disease.¹
Studies have shown that patients suffering from diabetes with two copies of the haptoglobin 2 variant are at a 5 times greater risk of heart attack and stroke.¹
MyHap2™ is a proprietary genetic test for Haptoglobin 1/2, People with a personal or family history of diabetes should be tested to evaluate their risk.
Order MyHap2™ to identify your diabetic patients with the highest risk of cardiovascular disease and stroke.
MyHap2™ Genotype Report:
• Cardiovascular Risk Level
• Interpretation of Risk
• Treatment Considerations
¹ Cahill LE et al. The risk of coronary heart disease associated with glycosylated hemoglobin of 6.5% or greater is pronounced in the Haptoglobin 2-2 genotype. JAM Coll Cardiol. 2015 Oct20:66(16):1791-1799.